The British Association for the Study of the Liver is a multi-disciplinary society with over 1,000 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
The British Association for the Study of the Liver aims to disseminate research findings and clinical expertise, to promote opportunities for collaboration in liver research, to provide a voice that can advise and interact with the media and advises policymakers.
The British Association for the Study of the Liver incorporates the British Liver Nurses's Association, the British Viral Hepatitis Group and the British Liver Transplant Group.
Membership covers BASL and all of its special interest groups; BLNA, BVHG and BLTG. Your Annual subscription is used to organise the Annual Meeting held each September and the subscription rate you pay is determined by your job status.
Dr Palak Trivedi (University of Birmingham) winner of the Andy Burroughs Young Investigator Award 2017.
Dr Fotis Sampaziotis (University of Cambridge) winner of the Dame Sheila Sherlock Award 2017 being presented with the award by the previous BASL Secretary Dr David Patch.
Find out more
Find out more about the work of our committee sub-groups and forums by clicking the logos below. These include The British Viral Hepatitis Group, British Association for the Study of the Liver Nurse Forum and the British Liver Transplant Group.
The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development.
BASL is a multi-disciplinary society with over 1,000 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
Members of BASL receive the following benefits:
- discounted registration rates for the annual meeting and other relevant meetings
- eligibility for the BASL Travel Awards (for members below status of Senior Lecturer or Consultant to allow presentation of high-quality UK liver research at International meetings, including the American Association for the Study of Liver Disease)
- eligibility for the prestigious Dame Sheila Sherlock Award (to an emerging researcher in the field of liver disease, for members below status of Senior Lecturer or consultant). Applications are usually submitted to the BASL Committee three months prior to the annual meeting - details are announced.
Click here to find out more about joining us.
The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2018 awards round on Tuesday 13th February. The final closing date for applications to the ACCEA is 17:00 on Thursday 12th April.
Application for BASL support
If you would like to apply for BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs as detailed below:
- Supplementary CV Questionnaire: Research & Innovation Assessment
- Supplementary CV Questionnaire: Teaching & Training Assessment
- Supplementary CV Questionnaire: Medical Leadership & Managing a High Quality Service Assessment.
Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.
Full application guidance can be found on the ACCEA website including the use of the Supplementary Forms by clicking here.
In addition BASL requires a short piece to accompany your application stating why you feel you should be supported by BASL.
The deadline for applying for BASL support is 17:00 on Friday 16th March 2018.
All applications must go through the ACCEA on line system, should you need a downloadable form to send to BASL these can be found on the ACCEA website by clicking here.
As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.
To apply for BASL support, please follow the steps below:
1. Send a completed ACCEA Application Form, along with a short piece as to why you feel you should be supported by BASL, to the BASL Secretariat, Judy.Hawksworth@execbs.com by 17:00 on Friday 16th March 2018.
Please understand that in fairness to all applicants, late submissions will not be considered.
2. All applicants are asked to provide the name of an individual who could write a supporting citation when submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.
3. You must submit your own application to ACCEA online by their deadline 17:00 on Thursday 12th April 2018. This is your own responsibility.
4. If you are in receipt of BASL support then BASL will upload your citation. You must ensure that your application is uploaded to the ACCEA website at least one week before the deadline - 17:00 on Thursday 5th April 2018, so that BASL has sufficient time to upload your citations onto your application on the ACCEA website.
Read the summary of the report from the first BVHG and BASL Best Practice for ODN Stakeholders Meeting which was held on the 10–11 January 2018 in Manchester on the BVHG page of the website by clicking here.
The report highlights the limitations of the current HCV treatment model, and provides suggestions on how it can be modified and improved. The report describes best practice examples for eliminating HCV for ODNs to take and adapt to work in their area. The intention is that this information will provide all ODNs with a framework to develop the 5-year plans needed to meet their CQUIN requirement, and importantly to also leave them well placed to deliver on the World Health Organisations goal of HCV elimination by 2030.
Alcohol Health Alliance - Policy and Advocacy Manager
For the Alcohol Health Alliance UK based at the Institute of Alcohol Studies
Salary £35,000 per year including London weighting
Fixed 24-month contract
A copy of the Job Description and details on how to apply can be downloaded here: Download Job Description policy manager AHA Feb 2018 with interview dates.pdf
Or viewed on the AHA website: http://ahauk.org/aha-vacancy-policy-advocacy-manager/ .
Apply for this role
To apply for this role, please send a CV and cover letter outlining how you meet the criteria to Kellie Donaldson at email@example.com .
The deadline for applications is 5pm Friday 23rd February 2018.
First interviews will be held on Wednesday 7th March 2018 and successful candidates will be invited back for final interviews on Monday 19th March 2018.
The UK Liver Pathology Group (UKLPG) was formed in 2016, evolving from the UK Liver EQA Scheme and the Liver subcommittee of the Pathology Section of the BSG, with the purpose of promoting excellence in liver histopathology services in the UK and Ireland, across all levels of specialisation, through professional collaboration in education, quality assurance and research.
The Research subcommittee aims to act as a source of histopathological advice for clinicians and scientists undertaking clinical, translational or pre-clinical research (including animal modelling), particularly those lacking local pathological support and resources.
The subcommittee welcome enquiries by email to UKLPG.Research@gmail.com .
UKLPG Research subcommittee
Dr Dina Tiniakos (Chair), Newcastle University
Prof Rob Goldin, Imperial College London
Dr Tu Vinh Luong, Royal Free London
Dr Tim Kendall, University of Edinburgh
Dr Ben Challoner, Guy's and St Thomas' NHS Foundation Trust
For details about the UKLPG, please see our website: http://www.virtualpathology.leeds.ac.uk/eqa/specialist/liver/index.php .
Download a copy of the information as a flyer here to share amongst colleagues; Download UKLPG Research subcommittee.pdf
Clinical Research Associate in Hepatology (Autoimmune Liver Disease)
Salary: £28,641 - £48,123 per annum
Closing date: 2 March 2018
Applications are invited for the post of Clinical Research Associate based in the Institute of Cellular Medicine (ICM) at Newcastle University, to pursue a programme of research in liver disease with a particular focus on Autoimmune Liver Disease. You will benefit from working in a group with an international reputation for its research and clinical practice in liver disease and from close interaction with the Stratified Medicine, Biomarkers and Therapeutics and Inflammation, Immunology and Immunotherapy themes in ICM. You will also be appointed an Honorary Registrar at Newcastle upon Tyne Hospitals NHS Foundation Trust contributing to specialist liver clinics and taking part in the out of hours tertiary liver unit on call rota. This will give you tertiary liver unit experience.
You will be expected to have some experience with audit and/or research and to be undertaking or completed higher specialist training in gastroenterology/hepatology. The key attribute, however, is enthusiasm to realise the opportunities offered by the post.
You must be in possession of MRCP or equivalent, with a valid full GMC Registration to eligible to apply.
This is a 2 year post with the potential to extend to a third year.
To apply, please visit the Newcastle University vacancies website.
The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant. This is an attempt to gather data on both numbers and outcomes of women with Pregnancy and Chronic Liver Disease in the UK.
The lead investigators are Professor Cath Williamson and Professor Michael Heneghan.
The ask from Hepatologists & BASL Membership is to let patients know who are pregnant to ask their local Obstetric service to include them in the data collection for the UKOSS Study.
Thank you for your help.
Government and the alcohol industry are failing to provide drinkers with the information they need to make the right choices about alcohol – both for themselves and for their children.
New figures released show that only 16% people are aware of the weekly alcohol guidelines, 2 years after the guidelines were announced.
They also reveal that parents are not equipped with the right information to keep their children safe from alcohol harm, with fewer than 1 in 20 aware of the official advice on children’s drinking.
The figures come from the Alcohol Health Alliance UK (AHA), who surveyed the UK public on their attitudes to alcohol in September 2017.
The low-risk weekly drinking guideline for adults is 14 units a week – around 6 pints of 4% beer, or 6 medium glasses of wine. This guideline was announced by the UK’s Chief Medical Officers in January 2016.
For children, the official advice is that an alcohol-free childhood is best, due to evidence of a wide range of short term and long term harms linked to children’s drinking.
In England, the Chief Medical Officer says that if children do try alcohol, they should be at least 15 years old, and be in a supervised environment.
The recommendation that an alcohol-free childhood free is best is based on the fact that young people are physically unable to tolerate alcohol as well as adults, and young people who drink are more likely to engage in unsafe sex, try drugs, and fall behind in school.
In addition, the younger someone starts drinking, the more likely they are to develop a problem with alcohol when they are older.
This goes against the commonly held view that allowing children to drink at home at a young age will teach them to be responsible drinkers when they are adults. The AHA survey found that this view was common, with 6 in 10 people agreeing that children who drink at home will ‘know how to handle their drink when they’re older’, and that children who drink in moderation at home ‘are less likely to binge on their own.’
Whilst awareness of the alcohol guidelines for both adults and children is low, the AHA’s survey found that there is an appetite among the public for greater information on the risks linked with drinking, with high levels of support for the inclusion of warning messages on alcohol labels.
Eight out of 10 people want alcohol labels to include the weekly guidelines, and a warning that exceeding the guidelines can damage your health.
80% of people also want labels to include a warning that alcohol is linked with cancer. Alcohol is known to be linked with at least seven types of cancer, and has been classed as a class 1 carcinogen, along with tobacco, by the UN-linked International Agency for Research on Cancer. The alcohol industry has been found to mislead the public on this link, by denying or distracting away from it*, and industry bodies recently lobbied successfully in Canada to have a trial of cancer labels on alcohol products halted.
Commenting on the results of the AHA’s polling, Professor Sir Ian Gilmore, chair of the AHA, said that more should be done to ensure the guidelines for both adults and children are communicated to the public. He said:
‘It is really disappointing that only 16% of the public are aware of the alcohol guidelines for adults, and that fewer than 1 in 20 are aware of the advice around children’s drinking. The public have the right to know the Chief Medical Officers’ guidelines, so that they are empowered to make informed choices about their drinking. The same applies to parents, who want to do the right thing by their children and deserve to be informed of the Chief Medical Officers’ guidance on children and alcohol.
‘It is clear from our polling that the public want to be informed of the risks linked with alcohol, including the link with cancer, and that they want to see clear warning information on alcohol labels about the drinking guidelines and the risks of drinking at levels above these guidelines.
‘To this end, the government should introduce mandatory labelling of all alcoholic products, to ensure that the public and parents are fully informed about the risks.
‘In addition, the government should develop national information campaigns, informing the public and parents of the guidelines for both adults and children.’
Commenting on the survey’s findings around alcohol and cancer, Caroline Moye, Head of World Cancer Research Fund UK (WCRF UK), said:
‘AHA’s new research shows a clear public call for alcohol product labels to carry a warning about the link between alcohol and cancer, and the Government should put these warning labels in place. Government cannot leave the communication of cancer risks to the alcohol industry.
‘For anyone who drinks alcohol, we recommend they stay within the weekly guideline of 14 units a week, though abstaining from alcohol altogether will reduce their cancer risk even more. We have many tips for cutting down on alcohol, including drinking out of smaller glasses, diluting drinks such as swapping pints for a spritzer and aiming to keep at least a few days each week alcohol-free. People can get more information about our Cancer Prevention Recommendations at https://www.wcrf-uk.org/uk/preventing-cancer/cancer-prevention-recommendations.'
The AHA’s polling was carried out in September 2017. 2,000 people across the UK (1,671 in England, 165 in Scotland, 110 in Wales and 54 in Northern Ireland) were surveyed on the AHA’s behalf by the national polling company OnePoll, and the results were then weighted to ensure they are nationally representative.
OnePoll works according to the Market Research Society’s code of conduct. This code helped ensure, for example, that none of the survey questions could be considered as leading.
Key statistics from the polling include:
- Only 16% of people are aware of the low-risk weekly drinking guideline of 14 units
- Only 3% of people are aware of the guidance that an alcohol-free childhood is best
- Only 10% of people mention cancer when asked which diseases and illnesses are linked to alcohol
- 81% believe the weekly guidelines should appear on alcohol labels
- 78% believe labels should include a warning that exceeding the guidelines can damage your health
- 77% of people support a cancer warning on alcohol product labels
- 73% believe labels should include calorie information
- 55% of people believe that ‘providing children with alcohol in a supervised situation will ensure that they know how to handle drinking when they’re older’.
- 57% of people believe that ‘children that drink alcohol in moderation with their own family are less likely to binge on their own’.
- 77% of people believe that the UK has an ‘unhealthy’ relationship with alcohol
- 52% think that the government is not doing enough to tackle the problems with alcohol in society
The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies.
For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at firstname.lastname@example.org or on 0203 075 1726.
NICE is currently recruiting for additional members to join their Quality Standards Advisory Committee (QSAC) to support delivery of the library quality standards topics.
NICE quality standards are a set of concise, prioritised statements and associated measures that focus on topics relevant to health and/or social care. Quality standards describe high-priority areas for quality improvement in a defined care or service area.
They are looking to appoint a number of standing members with the following backgrounds/expertise:
• Secondary care practitioners - For example doctors, nurses, or allied health professionals, in secondary care.
• Public health practitioner - For example those from local authorities, and PHE regional teams.
• Commissioners of health, public health and social care services - For example those from clinical commissioning groups or local authorities and those with experience of service redesign to improve quality and outcomes for people with care and support needs.
• Safety expert - For example people who take a lead in addressing issues of relating to risk and safety, for example risk managers and safeguarding leads
• Lay member
NICE’s quality standards are central to supporting the Government's vision for a health and social care system focused on delivering the best possible outcomes for people who use services. Derived from NICE guidance and other accredited sources, they are a concise set of prioritised statements designed to drive measurable quality improvements within a particular area of health or care and are becoming the backbone of the new commissioning system for health and social care.
If you have an interest in driving quality improvement in health, public health or social care, experience of working on committees and working groups, and highly developed interpersonal, communication and team working skills, then NICE would like to hear from you.
You will not be representing your organisation but will bring your expertise, experience and knowledge of current practice. The time commitment is one day a month, for a three year period, and your expenses will be reimbursed (if you are a general practitioner, locum cover will be covered).
More information on how to apply can be found at www.nice.org.uk/get-involved/join-a-committee and information on NICE quality standards at www.nice.org.uk/standards-and-indicators
You can also contact Rachel Neary-Jones at NICE on email@example.com .
The closing date for applications is 5pm Monday 15 January 2018.
The Quality Standards Team
National Institute for Health and Care Excellence
This well established course designed for pathologists and hepatologists runs for the 8th time in February 2018. The course is intended to provide a practical diagnostic approach to reporting liver biopsies from patients with medical liver diseases.
To view the programme and to register visit the RCPath website by clicking > here.
Venue: Royal College Of Psychiatrists, 21 Prescot St, Whitechapel, London E1 8BB.
The first British Viral Hepatitis Group (BVHG) meeting in 2018 will take place on Friday 2nd March at The Hallam Conference Centre, London.
The BVHG aims to improve the management and study of patients with chronic viral liver disease. The group brings together UK hepatologists, gastroenterologists, infectious disease physicians as well as virologists and epidemiologists with an interest in viral diseases of the liver.
The meeting will address the important issue of HIV and the Liver. Whilst treatments for HCV in HIV infected individuals has come a long way, there are many liver specific challenges that remain in the HIV field. We will be hearing about these from our eminent panel of speakers. Delegate participation is encouraged at the meeting.
The meeting is FREE to BASL / BVHG members (a deposit is taken at the time of booking) and non-members are welcome at a cost of £45.00.
REGISTRATION NOW OPEN - https://www.basl.org.uk/conference-booking/book-now.cfm?e=37
A draft programme can be viewed here. Download Programme BVHG BHIVA meeting 2nd March 2018.pdf
For further information, please contact Kim Girling at firstname.lastname@example.org or telephone 01543 442154.
We would like to thank our sponsors:
Premier Supporter: Gilead Sciences
Key Supporters: MSD and Cepheid
We would like to invite any interested BASL members to join the End of Life Care in Liver Disease Special Interest Group (SIG).
The inaugural meeting of the group is taking place on Tuesday 6 March 2018 from 10.30 - 16.00.
Venue: Room LF8, Level F, South Academic Block, Southampton General Hospital, Tremona road, Southampton SO16 6 YD.
A provisional programme is available here > Download BASL-End of Life Care-Prov Programme Mar 2018.pdf
Please note that this is not an educational event per se and members should have an active interest in End of Life Care in Liver Disease / able to contribute to the group.
If you are a BASL member and are unable to attend the meeting on 6th March but wish to join the group then we would be happy to include you in any future circulations.
The formal Chair of the End of Life Care in Liver Disease SIG will be decided in due course but for the purpose of getting the initial meeting set up Dr Mark Wright has been given an overseeing task by the outgoing BASL President.
If you are a BASL member and interested in joining the End of Life Care in Liver Disease SIG and attending the meeting please contact Dr Mark Wright directly at Mark.email@example.com .
A course jointly organised by the Hepatology and Metabolic Center, Leuven and the Charles Dent Metabolic Unit, London. This course will include up to date, state of the art lectures and debates, with expert European speakers, regarding current evidence for predicting / preventing complications, and treatment, including transplant and its outcomes, in inherited liver disease. Disorders covered will include the glycogen storage disorders, disorders of glycosylation, lysosomal acid lipase deficiency, disorders of bile acid synthesis, the organic acidemias, Wilson disease and mitochondrial disease. The latest advances in gene therapy and stem cell therapy for metabolic liver disease and the role of circulating microRNAs will also be discussed.
The course is aimed at: Consultants, senior trainees and scientists with a specific interest in inherited metabolic disease, hepatology or liver transplant. Paediatric or adult practice.
View the full details and programme here > Download Hepatic disease_Leuven 8-9 March 2018.pdf
Fees - the course fees of 450€ cover:
- 2 nights hotel accommodation (7th and 8th March) including breakfast.
- Lunch, coffee and dinner during the course.
A local fee of 315€ is granted if accommodation is not needed.
Participants are responsible for their own travel arrangements to and from the course. Fees are not refundable.
Registration process and deadline
The registration form should be completed on-line: www.rrd-foundation.org and submitted with your curriculum vitae in English. No payment is required at this stage.
Deadline for registration is 10th of January 2018.
Selection criteria and review process:
Candidates will be selected based on their background, experience and geographical breakdown.
The scientific organising committee will review the applications and select participants.
Selection decisions will be announced within 10 days following the deadline for registration.
Accreditation - an application will be made for European CME (EACCME).
The conference program will have high quality content with up-to-date information by eminent researchers and clinicians, covering all aspects of Hepatology.
The conference will provide an avenue for cooperation and collaboration amongst various institutions, academicia, companies, associations, non-profit organizations, and other related sectors, to deliver benefits to the people in the Asian Pacific region, where liver disease continues to be a major problem area.
This would be the perfect opportunity for all of us to share our views, values, experiences and practices regarding liver diseases, such as Viral Hepatitis, Liver Cancers, NASH, Liver Failure, Portal hypertension, Alcoholic Liver Disease, Liver Transplantation, Pediatric Liver Diseases, Liver Radiology, and other topics.
To find out all of the information visit the conference website by clicking> here.
The BLTG School of Transplantation for 2018 is taking place on Wednesday 14th March in Brighton.
The School of Transplantation offers an excellent platform for trainees in liver transplantation with lectures delivered by carefully selected leading speakers from the UK.
This meeting is a one day standalone event that will run in parallel with the first day of the British Transplantation Society Congress at the same venue; The Brighton Centre, Brighton.
The meeting is FREE to BASL members (a deposit is taken at the time of booking) and with numbers restricted to 40 places early booking is advisable to avoid disappointment.
REGISTRATION IS NOW OPEN
A draft programme is available: Download School of Transplantation Programme 2018.pdf
We would like to thank our sponsors for their support:
Complete Supporter - Norgine
For further information please contact Kim Girling at firstname.lastname@example.org or telephone 01543 442154.
A focused curriculum-based update course in Gastroenterology & Hepatology for Gastroenterology SPRs approaching the SCE exam.
Venue: Queen's Medical Centre, Nottingham.
The course will include: a pre and post course exam, an introduction to answering SBAs, lectures from experienced consultants with time for Q&As, and comprehensive coverage of the required syllabus.
Fee - the course fee is £120 for the two day course, but candidates from within the Deanery will be free of charge if this is their first attendance at this course (else standard fee applies).
For further information and to book a place visit the website by clicking here.
On behalf of Prof Ellie Barnes from Oxford, and Dr George Webster from London we are delighted to ask you to SAVE THE DATE for the UK's first IgG4 Related Disease Symposium, to be held at the Royal College of Physicians, London, Friday 23rd March 2018.
This exciting event will bring together the wide range of specialities involved in this recently described and fascinating disease. As well as addressing the history, immunology and pathogenesis of IgG4-RD, we will also be exploring the clinical manifestations and management of affected sites, including:
• Liver and pancreaticobiliary system
• Kidneys and retroperitoneum
• Nervous system
We will be joined by a fantastic national and international expert faculty, including John Stone, Professor of Medicine, Harvard Medical School and Director of Clinical Rheumatology Massachusetts General Hospital, who has done so much to advance our understanding and management of IgG4-RD.
If you would like to attend, please reply to myself via e-mail: email@example.com and I will add you on our invitations list to ensure you are kept up to date with the latest details.
Further details will be sent out to all in a timely manner.
We are pleased to announce that the liver disease quality standard (QS152) has been published on the NICE website.
You can view the quality standard by clicking > here.
BASL has formally supported the liver disease quality standard.
ACCEA 2018 Round Open - Apply for BASL support - click here to read more.
Join BASL Ward Membership Today - £100 per annum for up to 5 members per ward.
Download a flyer for your noticeboard - Download BASLNF Ward Membership Flyer May 17.pdf.
To find out how to apply click here
Click here to view the BASL Newsletter - January 2018.
The BASL Nurse Toolkits were developed following conversations with nurse specialists. These and a later email survey identified training needs to help nurses meet the liver nurse competencies. To access the Learning Toolkits sign in as a BASL Member and click on Manage Account